MedTrace Logo

Effects of Low Dose Neuromuscular Blocker Usage on Laryngeal Mask Application

NCT03424356 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2018-06-13

No results posted yet for this study

Summary

Cystoscopy is a simple, effective and reliable method in current urological practice. Anesthesia may be required in cystoscopy for therapeutic purpose, however it may not be necessary for diagnostic cystoscopy. General anesthesia, spinal anesthesia, epidural anaesthesia and senile block methods may be performed in therapeutic cystoscopy.

Pain is main reason of failed cystoscopy. Sedo-analgesia and LMA are generally used for diagnostic cystoscopies. LMA is mostly placed under general anesthesia with the combination of propofol-fentanyl and volatile anesthetics. There is no need for muscle relaxant administration in LMA placement, as it is necessary for intubation. However if muscle relaxant is not used, side effects like hiccup, straining, cough, undesirable muscle movement, hypoxia and laryngeal spasm may be observed.

For the improvement of the patient comfort the use of effective muscle relaxants are described in several studies in literature. This study aimed to reveal the quality of anesthesia, hemodynamics, surgical comfort, extra propofol need and recovery time while low dose of muscle relaxant rocuronium was added to propofol-fentanyl combination for LMA placement.

Conditions

  • Anesthesia

Interventions

DRUG

Rocuronium Bromide

0.15 mg/kg rocuronium bromide

DRUG

Saline Solution

1-2 ml saline solution

DRUG

Fentanyl

1mcg/kg for induction

DRUG

Propofol

2-3mg/kg for anaesthetic induction

PROCEDURE

cystoscopy

patients will treated with this surgical procedure

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • ayşe ülgey, md · TC Erciyes University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-04
Primary Completion
2018-12-04
Completion
2018-12-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03424356 on ClinicalTrials.gov